Improvement in Asthma Control Using a Minimally Burdensome and Proactive Smartphone Application.
Improvement in Asthma Control Using a Minimally Burdensome and Proactive Smartphone Application.
复制标题
DOI：
10.1016/j.jaip.2016.03.005
复制
发表时间：
2016-07
期刊：
影响因子：
--
通讯作者：
Simon RA
中科院分区：
文献类型：
--
作者：
Cook KA;Modena BD;Simon RA
综合慢性疾病治疗模式，使患者自我护理和共享治疗决策，最近已被证明可以改善药物依从性和结果。智能手机应用程序（app）是实现这种模式的现成手段，尽管持续的用户粘性仍然是个挑战。评估使用主动智能手机应用程序改善哮喘控制的效果，而无需定期输入。我们设计了一款微创智能手机应用程序，根据国家哮喘教育和预防计划指南和Scripps管理路径，为哮喘患者提供个性化和及时的支持。在这项概念验证研究中，我们招募了60名哮喘控制不佳的成年人，在4个月的时间里测试了这款应用程序的可用性和有效性。哮喘控制测试调查用于评估应用程序使用前、期间和之后的控制情况。作为一个推论，回顾性图表审查也被用来评估肺功能的变化和规定的全体性皮质类固醇疗程。我们的患者平均年龄为50岁，在研究期间，哮喘控制测试分数从16.6分（不足到差）改善到20.5分（控制）。同时，FEV1绝对增加7.9%，而全身性皮质类固醇疗程从每6个月0.5个疗程减少到0.3个疗程。60例患者中有58例完成了最终调查，满意度较高。该应用程序改善了一组未控制哮喘的患者（年龄范围，17-82岁）的哮喘控制，同时最大限度地减少了繁琐的投入，并主动提供个性化的教学和治疗支持。该应用程序和治疗模式是可扩展的，可以经济有效地管理慢性病。
Integrated chronic disease treatment models that enable patient self-care and shared treatment decision making have recently been shown to improve medication adherence and outcomes. Smartphone applications (apps) are a readily available means to enable this model, although sustained user engagement remains a challenge. To assess the efficacy of improving asthma control using a proactive smartphone app without required regular inputs. We designed a minimally intrusive smartphone app to provide individualized and timely support to patients with asthma based on the National Asthma Education and Prevention Program guidelines and Scripps management pathways. In this proof-of-concept study, we enrolled 60 adults with poorly controlled asthma to test the usability and effectiveness of this app over a 4-month period. The Asthma Control Test survey was used to assess control before, during, and after app use. As a corollary, a retrospective chart review was also used to assess changes in lung function and prescribed courses of systemic corticosteroids. Our patients, with a mean age of 50 years, reported an improvement in Asthma Control Test scores from 16.6 (inadequate to poor) to 20.5 (controlled) over the study period. Concurrently, there was a 7.9% absolute increase in FEV1, while courses of systemic corticosteroids decreased from 0.5 to 0.3 courses per 6-month period. Fifty-eight of 60 patients completed the final survey, with high satisfaction reported. This app improved asthma control in a cohort of patients with uncontrolled asthma (age range, 17–82 years), while minimizing burdensome inputs and proactively providing individualized teaching and treatment support. The app and treatment model are scalable to cost-effectively manage chronic disease.
登录
查看更多内容
影响因子：
4.7
作者：
Lv, Yanhua;Zhao, Haijin;Cai, Shaoxi
通讯作者：
Cai, Shaoxi
影响因子：
2.6
作者：
Bender, BG;Bender, SE
通讯作者：
Bender, SE
DOI：
10.1136/bmj.e1756
发表时间：
2012-03-23
期刊：
BMJ (Clinical research ed.)
影响因子：
--
作者：
Ryan D;Price D;Musgrave SD;Malhotra S;Lee AJ;Ayansina D;Sheikh A;Tarassenko L;Pagliari C;Pinnock H
通讯作者：
Pinnock H
影响因子：
2.2
作者：
Licskai, Christopher J.;Sands, Todd W.;Ferrone, Madonna
通讯作者：
Ferrone, Madonna
影响因子：
1.9
作者：
Burbank, Allison J.;Lewis, Shannon D.;Perry, Tamara T.
通讯作者：
Perry, Tamara T.